Stay current on changes and developments in corporate law with a wide variety of resources and tools.
Dec. 4 — A Delaware Supreme Court ruling affirming that the Royal Bank of Canada (RBC) was liable for aiding and abetting Rural/Metro Corp. directors' breaches of fiduciary duty provides important guidance for boards looking to get deals done, attorneys told Bloomberg BNA.
While corporate directors themselves often are shielded from individual liability for breaches of duty by exculpatory charter provisions, the case suggests ways in which boards can avoid financial adviser conflicts and costly litigation, Lawrence Hamermesh, a professor from Widener University Delaware Law School, told Bloomberg BNA Dec. 4.
In a Nov. 30 opinion, the state high court affirmed four chancery court rulings finding RBC liable to Rural/Metro stockholders for aiding and abetting the board's breaches of duty in connection with a $438 million buyout (30 CCW 361, 12/2/15).
In an interview, Hamermesh said that the decision represents a resurrection of Revlon‘s enhanced standard of review—which he said has become “dead-letter” law.
In this case, the court found that Revlon could be used for purposes of holding RBC liable for aiding and abetting the board's underlying breaches of duty, even though the directors were shielded from a damages award, he observed.
The court concluded that the directors breached their duties even without being disloyal and without engaging in grossly negligent behavior, Hamermesh noted. Instead, the court reasoned that breaches were predicated upon the board “not running an auction in a way that comported within the bounds of reasonableness,” which is a considerably less deferential inquiry than the business-judgment rule, he said.
Hamermesh said that when hiring investment bankers, directors have an obligation to take reasonable steps to determine throughout the transaction that the advisers are not conflicted, or ensure that the board fully understands all material conflicts.
He added that a “rapidly developing” area in deal making is determining what kind of disclosures are reasonable to expect and what is too much to ask for.
Similarly, former Delaware Supreme Court Justice Henry duPont Ridgely, who now is senior counsel with DLA Piper, and John L. Reed, the partner in charge of DLA Piper's Delaware litigation practice, told Bloomberg BNA in a joint Dec. 2 e-mail that directors must be active and informed when overseeing the sale process. “This includes requiring disclosure by the financial advisor at the outset and on an ongoing basis of material conflicts that might impact the board's process,” they said.
“Permissive language in an engagement letter allowing a financial advisor to explore staple financing is not enough to satisfy this disclosure obligation,” the DLA Piper attorneys continued. “While a board may consent to conflicts, directors must be especially diligent in overseeing a conflicted advisor's role in the sale process.”
Ridgely and Reed also said that the RBC case is instructive as to when enhanced scrutiny under Revlon begins. They noted that the RBC decision involved an unusual fact scenario in that the bank was engaged to sell Rural/Metro without board authorization, and the board later ratified that action. “Enhanced judicial scrutiny under Revlon is triggered not only when a board decides to sell the company but even earlier, if the board ratifies unauthorized action by a CEO and special committee to initiate an active bidding process,” they said.
Moreover, the DLA Piper attorneys said that under Revlon, once a company is for sale, a board has a “situational duty” derived from the duties of care and loyalty to maximize the sale price of the company.
“Delaware courts will examine the overall course of action to determine whether that course of action was reasonable under the circumstances as a good faith attempt to secure the highest value reasonably available,” they said.
In other takeaways, Ridgely and Reed noted that directors breach their duty of disclosure by falsely representing the financial advisers' analysis and by not fully disclosing “unquestionably material” information that the financial advisers were using the sale process to pursue financing business with a bidder.
To contact the reporter on this story: Michael Greene in Washington at firstname.lastname@example.org
To contact the editor responsible for this story: Yin Wilczek at email@example.com
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)